Nanomedicine News

RSS

Researcher Achieves Breakthrough in DNA Analysis using Nanoparticles

The time consuming process of performing DNA analysis has been reduced to a matter of minutes, thanks to the research headed by Donald K Roper, an associate professor of chemical engineering at the University of Arkansas.

7 Oct 2011

Successful Phase 1 Clinical Trial of Nanotherapeutics Influenza Vaccine

Nanotherapeutics, Inc. announced the successful completion of a Phase 1 clinical trial of GelVac Nasal Dry-Powder H5N1 Influenza Vaccine. The trial assessed the safety of the novel intranasal dry-powder formulation vacci...

From Nanotherapeutics Inc. 4 Oct 2011

NCI Provides Grant to NanoSort to Develop Lab-on-a-chip Devices for Detecting Cancer Cells

NanoSort, a start up biomedical device manufacturer, has received a two-year grant worth $297,000 from the National Cancer Institute for Small Business Innovation Research. NCI has also granted a contract worth $198,000 to NanoSort.

3 Oct 2011

EGEN, Nanotechnology Characterization Laboratory Partner to Accelerate Human Clinical Trial of Brain Cancer Therapy

EGEN and the Nanotechnology Characterization Laboratory of the National Cancer Institute (NCI) have partnered to speed up the human clinical trial of EGEN’s nanoparticle-based gene therapy for the treatment of brain cancer.

29 Sep 2011

NanoViricides’ CEO to Discuss Company’s Latest Developments at NanoBusiness Conference

Dr. Anil R. Diwan, NanoViricides’ President and Chief Executive Officer, will deliver a presentation at the 10th Annual NanoBusiness Conference/NanoManufacturing Summit being conducted at the Seaport World Trade Center located in Boston, Massachusetts.

From NanoViricides, Inc 28 Sep 2011

Silver Nanoparticle Biotags for Identifying Cancerous Prostate Cells

UC Santa Barbara researchers have developed a novel technology for distinguishing prostate cancer cells in bodily fluids. The technology holds potential for developing a microdevice that would help understand when metastasis of prostate cancer would occur.

21 Sep 2011

NanoViricides Plans cGMP Pilot Plant for Nanoviricides Drug Candidates in Connecticut

NanoViricides has declared that a special purpose company Inno-Haven has closed the purchase of a light industrial building where NanoViricides plans to lease a portion to house its laboratory and current good manufacturing practices (cGMP) production facilities for its nanoviricides drug candidates for the treatment of several viral diseases.

From NanoViricides, Inc 21 Sep 2011